166 related articles for article (PubMed ID: 11900693)
1. [Pure red cell aplasia in a lung transplant patient].
Acosta O; Tarín F; León A; Moreno A; Bello MD; Pérez A
Arch Bronconeumol; 2002 Mar; 38(3):147-9. PubMed ID: 11900693
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Kidney Transplant Recipients With Multiple Relapsing Pure Red Cell Aplasia Due to Parvovirus B19 Infection.
Ersal T; Özkalemkaş F; Özkocaman V; Sezen M; Yalçın C; Orhan B; Candar Ö; Çubukçu S; Koca TG
Exp Clin Transplant; 2024 Jan; 22(1):75-79. PubMed ID: 36259607
[TBL] [Abstract][Full Text] [Related]
3. [Parvovirus B19-induced pure red cell aplasia in a liver transplant recipient].
Lee EY; Cho Y; Lee SG; Song J
Korean J Lab Med; 2010 Dec; 30(6):591-4. PubMed ID: 21157144
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19: A Rare Cause of Post-renal Transplant Anemia.
Ahmed W; Dogar RUH; Acharya S
J Coll Physicians Surg Pak; 2017 Dec; 27(12):785-787. PubMed ID: 29185410
[TBL] [Abstract][Full Text] [Related]
6. A case of parvovirus B19-induced pure red cell aplasia in a child following heart transplant.
Kelleher E; McMahon C; McMahon CJ
Cardiol Young; 2015 Feb; 25(2):373-5. PubMed ID: 24555951
[TBL] [Abstract][Full Text] [Related]
7. Isolated Anemia in a 69-Year-Old Man with HIV-1: Features of Pure Red Cell Aplasia Mediated by Chronic Parvovirus-B19 Infection.
Wylde J; Berneri MA; Malherbe JAJ; Davel S
Am J Case Rep; 2022 Jul; 23():e936445. PubMed ID: 35871772
[TBL] [Abstract][Full Text] [Related]
8. Persistent pure red cell aplasia due to parvovirus B19 infection in a patient with Turner's syndrome.
Pitchaipillai S; Kelsey P; Haeney M
Clin Lab Haematol; 2006 Oct; 28(5):347-50. PubMed ID: 16999728
[No Abstract] [Full Text] [Related]
9. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature.
Geetha D; Zachary JB; Baldado HM; Kronz JD; Kraus ES
Clin Transplant; 2000 Dec; 14(6):586-91. PubMed ID: 11127313
[TBL] [Abstract][Full Text] [Related]
10. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.
Tiong M; Casan J; McLean C
Transpl Infect Dis; 2019 Apr; 21(2):e13045. PubMed ID: 30586222
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.
Zhang M; Zhong X; Zhang W; Xu J; Zhang M; Shen Y; Wang W; Zheng S
Int J Clin Pract Suppl; 2015 May; (183):29-34. PubMed ID: 26177162
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus b19 infection in HIV patient with pure red cell aplasia.
Sanphasitvong W; Poovorawan K; Boonsuk P; Assanasen T; Na Nakorn T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1216-20. PubMed ID: 16438148
[TBL] [Abstract][Full Text] [Related]
13. Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1. Recovery with alpha-interferon therapy.
Martins A; Costa A; Oliveira MJ; Rodrigues M; Ribeiro AP; Silvestre F; Reis A
Sangre (Barc); 1998 Feb; 43(1):67-9. PubMed ID: 9577184
[TBL] [Abstract][Full Text] [Related]
14. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection.
Choi SH; Chang SP; Won JC; Lee JS; Chi HS; Yang WS; Park SK
Scand J Infect Dis; 2002; 34(1):71-5. PubMed ID: 11874173
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of Pure Red Cell Aplasia in a Kidney Transplant Recipient Due to Reactivation of Parvovirus B19 Infection Despite Two Cycles of Intravenous Immunoglobulin Therapy.
Kaya B; Paydas S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):195-197. PubMed ID: 30777553
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
Crabol Y; Terrier B; Rozenberg F; Pestre V; Legendre C; Hermine O; Montagnier-Petrissans C; Guillevin L; Mouthon L;
Clin Infect Dis; 2013 Apr; 56(7):968-77. PubMed ID: 23243178
[TBL] [Abstract][Full Text] [Related]
17. Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient.
Alonci A; Penna G; Allegra A; D'Angelo A; Gangemi S; Ferraro M; Spatari G; Bacci F; Gerace D; Musolino C
Acta Oncol; 2011 May; 50(4):599-602. PubMed ID: 21529302
[No Abstract] [Full Text] [Related]
18. Parvovirus B19-associated transient red cell aplasia in children: the role of bone marrow examination in unusual presentations.
Garewal G; Ahluwalia J; Das R; Marwaha RK
Pediatr Hematol Oncol; 2004 Sep; 21(6):505-11. PubMed ID: 15552814
[TBL] [Abstract][Full Text] [Related]
19. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.
Arzouk N; Snanoudj R; Beauchamp-Nicoud A; Mourad G; Charpentier B; Tchernia G; Durrbach A
Transpl Int; 2006 Feb; 19(2):166-9. PubMed ID: 16441366
[TBL] [Abstract][Full Text] [Related]
20. Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia.
Mouthon L; Michel M; Gandré C; Montagnier-Petrissans C; Chevreul K
Clin Infect Dis; 2015 Feb; 60(3):488. PubMed ID: 25336624
[No Abstract] [Full Text] [Related]
[Next] [New Search]